A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

NCT06979453 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Deucravacitinib
OTHER: Placebo

Sponsor

Bristol-Myers Squibb